Literature DB >> 1618838

Increased expression of protein kinase C alpha plays a key role in retinoic acid-induced melanoma differentiation.

J R Gruber1, S Ohno, R M Niles.   

Abstract

Differentiation of B16 mouse melanoma cells induced by retinoic acid (RA) is preceded by a large increase in protein kinase C alpha (PKC alpha) mRNA and protein. To determine the role of PKC alpha in the differentiation program, we stably transfected B16-F1 cells with a plasmid containing the full length PKC alpha cDNA driven by an SV40 promoter. Two out of thirty-two colonies screened were determined to overexpress PKC by 2-4-fold according to Western blot analysis and PKC enzyme activity. When compared to control cells (wild-type cells and cells transfected only with the neomycin resistance gene), PKC alpha overexpressing clones displayed longer doubling times, diminished anchorage-independent growth, and increased melanin production. RA treatment of control cells mimicked these phenotypic characteristics. When injected subcutaneously into syngeneic mice, PKC alpha overexpressing clones produced smaller tumors and had longer latencies than control cells. These findings, combined with the fact that phorbol esters down-regulate PKC and antagonize RA action suggest that PKC alpha plays a key role in the RA-induced melanoma differentiation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1618838

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Classical Protein Kinase C: a novel kinase target in breast cancer.

Authors:  R K Singh; S Kumar; M S Tomar; P K Verma; S P Singh; P K Gautam; A Acharya
Journal:  Clin Transl Oncol       Date:  2018-07-30       Impact factor: 3.405

2.  Phenotype-specific inhibition of the vascular smooth muscle cell cycle by high glucose treatment.

Authors:  X-L Zheng; S-G Yuan; D-Q Peng
Journal:  Diabetologia       Date:  2007-02-14       Impact factor: 10.122

Review 3.  Regulation of protein kinase C and role in cancer biology.

Authors:  G C Blobe; L M Obeid; Y A Hannun
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

4.  Retinoic acid and cyclic AMP synergistically induce the expression of liver/bone/kidney-type alkaline phosphatase gene in L929 fibroblastic cells.

Authors:  M Giannì; M Terao; S Sozzani; E Garattini
Journal:  Biochem J       Date:  1993-11-15       Impact factor: 3.857

5.  Phosphorylated extracellular signal-regulated protein kinases 1 and 2 phosphorylate Sp1 on serine 59 and regulate cellular senescence via transcription of p21Sdi1/Cip1/Waf1.

Authors:  Hong Seok Kim; In Kyoung Lim
Journal:  J Biol Chem       Date:  2009-03-24       Impact factor: 5.157

6.  Constitutive c-myb expression in K562 cells inhibits induced erythroid differentiation but not tetradecanoyl phorbol acetate-induced megakaryocytic differentiation.

Authors:  D Rosson; T G O'Brien
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

7.  Treatment of mouse melanoma cells with phorbol 12-myristate 13-acetate counteracts mannosylerythritol lipid-induced growth arrest and apoptosis.

Authors:  X Zhao; C Geltinger; S Kishikawa; K Ohshima; T Murata; N Nomura; T Nakahara; K K Yokoyama
Journal:  Cytotechnology       Date:  2000-07       Impact factor: 2.058

Review 8.  The complexities of PKCα signaling in cancer.

Authors:  Adrian R Black; Jennifer D Black
Journal:  Adv Biol Regul       Date:  2020-11-23

9.  Protein kinase C signaling mediates a program of cell cycle withdrawal in the intestinal epithelium.

Authors:  M R Frey; J A Clark; O Leontieva; J M Uronis; A R Black; J D Black
Journal:  J Cell Biol       Date:  2000-11-13       Impact factor: 10.539

10.  Rosiglitzone suppresses angiotensin II-induced production of KLF5 and cell proliferation in rat vascular smooth muscle cells.

Authors:  Dengfeng Gao; Guanghua Hao; Zhe Meng; Ning Ning; Guang Yang; Zhongwei Liu; Xin Dong; Xiaolin Niu
Journal:  PLoS One       Date:  2015-04-14       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.